“We're going to Appraise how the commercialization of this substance fits in with our business model at Adastra in order to posture ourselves to support the demand from customers for a safe supply of copyright,” said Main govt officer Michael Forbes inside of a news launch. The corporate told VICE News it wouldn't be commenting even further.